"2","Positive for translocation or inversion events involving the ALK gene locus (e.g. resulting in EML4-ALK fusion) as defined by a Clinical Laboratory Improvement Act (CLIA)-approved test","Inclusion","ALK-positive NSCLC","ALK","N/A","(ALK-positive NSCLC) ∧ (EML4-ALK fusion)"
"2","ALK protein expression by immunohistochemistry (IHC)","Inclusion","ALK-positive NSCLC","ALK","N/A","(ALK-positive NSCLC) ∧ (IHC-positive)"
"2","ALK rearrangement identified by next generation (NextGen) sequencing","Inclusion","ALK-positive NSCLC","ALK","N/A","(ALK-positive NSCLC) ∧ (NGS-positive)"
"2","Patients must have completed any prior adjuvant chemotherapy or radiation therapy 2 or more weeks (6 or more weeks for mitomycin and nitrosoureas) prior to randomization and be adequately recovered at the time of randomization","Inclusion","Lung Cancer","-","Chemotherapy or radiation therapy","(completed adjuvant chemotherapy or radiation therapy ≥ 2 weeks prior to randomization) ∧ (adequately recovered at time of randomization)"
"2","Prior to randomization patients with any non-hematologic toxicity from surgery, chemotherapy, or radiation must have recovered to grade =< 1 with the exception of alopecia and the criteria outlined","Inclusion","None","None","Chemotherapy, surgery, radiation","Criterion Text = ""Prior to randomization patients with any non-hematologic toxicity from surgery, chemotherapy, or radiation must have recovered to grade =< 1 with the exception of alopecia and the criteria outlined"""
"2","No known interstitial fibrosis or interstitial lung disease","Exclusion","Interstitial fibrosis","-","-","!(has_interstitial_fibrosis ∨ has_interstitial_lung_disease)"
"2","No prior treatment with crizotinib or another ALK inhibitor","Exclusion","","","Crizotinib or another ALK inhibitor","Not(Prior Therapy contains Crizotinib or another ALK inhibitor)"
"2","Patients must not have any history of locally advanced or metastatic cancer requiring systemic therapy within 5 years from randomization, with the exception of in-situ carcinomas and non-melanoma skin cancer","Exclusion","None","None","History of locally advanced or metastatic cancer","¬(HasHistoryOfLocallyAdvancedOrMetastaticCancerWithin5YearsFromRandomization() ∧ HasInSituCarcinomaOrNonMelanomaSkinCancer())"
"2","Patients must have no previous primary lung cancer diagnosed concurrently or within the past 2 years","Exclusion","Lung cancer","None","Previous primary lung cancer diagnosis","¬(HasPreviousPrimaryLungCancerDiagnosisWithin2Years())"
